CAR T-Cell Therapy for Multiple Myeloma (MM)
Introduction: Multiple myeloma (MM) is an incurable haematological malignancy characterised by clonal expansion of abnormal plasma cells in the bone
Read more
Clinical Features
Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer
What is hormone receptor-positive breast cancer? Breast cancer subtypes can be characterised by the expression of oestrogen, progesterone and human
Read more
Testicular Cancer: Serve the Survivors
Testicular cancer, by nature, is one of the most aggressive solid organ tumours. It can spread to virtually every part
Read more
Emerging Treatments for Colorectal Cancer: Advancing Towards Precision Therapy
Introduction: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and second leading cause of cancer-related mortality worldwide. In
Read more
The Evolving Landscape of Neoadjuvant Therapy for Locally Advanced Rectal Cancer In Ireland
Introduction: The management of rectal cancer in Ireland has evolved significantly in recent years, driven by advancements in imaging, therapeutic modalities
Read more
All-Ireland Cancer Liquid Biopsies Consortium (CLuB) advancing Ovarian Cancer Research
The All-Ireland Liquid Biopsy Consortium (CLuB; www.clubcancer.ie) is a collaborative program focused on advancing liquid biopsy technologies for cancer diagnosis
Read more
TransAtlantic Cancer Alliance for Liquid Biopsy Research and Training
The TransAtlantic Cancer Alliance for Liquid Biopsy Research and Training project was recently funded by the HRB All-Ireland NCI Cancer
Read more
Prostate cancer incidence and mortality in Europe: implications for screening activities
Prostate cancer in Europe: the statistics Prostate cancer is the most commonly diagnosed cancer in men and the third leading
Read more
An Update on Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA) refers to a group of inflammatory arthritides of unknown cause that begin before 16 years of
Read more
The Hospital Pharmacists Association of Ireland Education and Research Specialist Interest Group
Background: In December 2024, the Hospital Pharmacists Association of Ireland (HPAI) established an Education and Research Specialist Interest Group (SIG).
Read more